Compare COEP & FNWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | COEP | FNWB |
|---|---|---|
| Founded | 2017 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 100.4M | 87.5M |
| IPO Year | N/A | 2012 |
| Metric | COEP | FNWB |
|---|---|---|
| Price | $13.05 | $9.27 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $13.50 |
| AVG Volume (30 Days) | 28.1K | ★ 28.2K |
| Earning Date | 01-01-0001 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.76% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $176,000.00 |
| Revenue This Year | N/A | $19.24 |
| Revenue Next Year | N/A | $8.90 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.32 | $7.05 |
| 52 Week High | $21.41 | $10.98 |
| Indicator | COEP | FNWB |
|---|---|---|
| Relative Strength Index (RSI) | 51.29 | 30.87 |
| Support Level | $10.74 | $7.56 |
| Resistance Level | $13.12 | $9.50 |
| Average True Range (ATR) | 0.84 | 0.31 |
| MACD | 0.20 | -0.07 |
| Stochastic Oscillator | 67.07 | 10.00 |
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.
First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.